← United States · All US Insider Profiles

US INSIDER PROFILE · NON-SCORING RESEARCH

O'Toole David D

Chief Financial Officer

Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001491140

Purchase history

Companies traded
1
Purchases · 12M
5
Purchases · 24M
10
Average purchase
$9.7K
Median purchase
$9.3K
Gross purchase value
$97.0K

Companies: AVITA Medical, Inc.

10 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.

Qualifying purchase disclosures

PublishedCompanyTickerRoleReported valueSEC source
2026-08-24AVITA Medical, Inc.RCELChief Financial Officer$7.9KOpen filing
2026-05-20AVITA Medical, Inc.RCELChief Financial Officer$8.5KOpen filing
2026-05-19AVITA Medical, Inc.RCELChief Financial Officer$8.5KOpen filing
2026-03-11AVITA Medical, Inc.RCELChief Financial Officer$8.6KOpen filing
2026-02-23AVITA Medical, Inc.RCELChief Financial Officer$12.5KOpen filing
2025-08-26AVITA Medical, Inc.RCELChief Financial Officer$9.0KOpen filing
2025-08-12AVITA Medical, Inc.RCELChief Financial Officer$9.6KOpen filing
2025-02-20AVITA Medical, Inc.RCELChief Financial Officer$9.9KOpen filing
2025-02-19AVITA Medical, Inc.RCELChief Financial Officer$10.2KOpen filing
2024-12-05AVITA Medical, Inc.RCELChief Financial Officer$12.2KOpen filing

Post-purchase outcomes

Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.

No completed point-in-time price outcome is available yet.

Research patterns

First purchase in 12M
0/9
Large purchase ≥ $100k
0/10
Cluster buying · 15D
2/10
Buying the dip
0/—

Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.

Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.